Medical tourism weakness in Singapore could be temporary: Maybank
Michelle Zhu • • 2 min read
SINGAPORE (June 5): Maybank Kim Eng Research continues to rate Raffles Medical Group (RMG) at “buy” as Singapore’s leading integrated healthcare provider, with a “robust track record and exciting development plans” of two hospitals in China.
Follow us on Facebook and join our Telegram channel for the latest updates.
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.